NCT04816851

Brief Summary

Prospective Cohort Study aims at elaborating the outcomes of the Tricuspid Reconstruction of Aortic valve leaflets using autologous pericardium (Ozaki procedure) in the adult and paediatric patients. A very promising technique with the potential benefits of dodging oral anticoagulation, foreign material, and suitable for patients with small aortic annuli and in infectious endocarditis. Performing hemodynamic evaluation, assess the clinical implementation and report preliminary results at follow up .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 25, 2021

Completed
5 days until next milestone

Study Start

First participant enrolled

March 30, 2021

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2023

Completed
Last Updated

January 20, 2025

Status Verified

January 1, 2025

Enrollment Period

2.3 years

First QC Date

March 19, 2021

Last Update Submit

January 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • aortic transvalvular gradient

    analyse aortic valve stenosis or insufficiency measured by transthoracic echocardiography

    at follow up frame through one year

Secondary Outcomes (3)

  • Duration of hospitalization

    average 5-7 days

  • number of patients developed complications

    through one year

  • conduction disturbances

    6 months post operative

Other Outcomes (2)

  • aortic valve re intervention or aortic regurge

    through one year

  • LV dimensions and EF%.

    through one year

Study Arms (1)

Ozaki group

Patients undergoing aortic valve reconstruction using autologous pericardium (OZAKI technique) at Assiut University Hospitals in conjunction with Al-Nas hospital in cairo.

Procedure: OZAKI technique

Interventions

an alternative way of repairing aortic valve, involving the use of autologous pericardium for the aortic leaflet reconstruction. Diseased leaflets are removed carefully. The distance between each commissure is measured with invented sizing apparatus. The new leaflet of the size corresponding to the measured value is trimmed with an original template from glutaraldehyde-treated autologous pericardium. Finally, the annular margin of the pericardial leaflet was running sutured with each annulus. Commissural coaptation was secured with additional sutures. The coaptation of three new leaflets were always insured with direct vision.

Ozaki group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing aortic valve reconstruction using autologous pericardium (OZAKI technique) at Assiut University Hospitals in conjunction with Al-Nas hospital in cairo.

You may qualify if:

  • Subject with AV disease.
  • Documented symptomatic moderate or greater aortic stenosis
  • small aortic annulus patients
  • A symptomatic aortic insufficiency patient with left ventricular dysfunction or significant left ventricular dilatation.
  • Patients with aortic regurgitation caused by: a dilated aortic annulus, conjoined cusp prolapse in bicuspid aortic valves (BAV), single cusp prolapse in tricuspid aortic valve (especially in paediatric population), and aortic valve cusp perforation from endocarditis.
  • Concomitant intervention of the aortic root, Concomitant intervention of the aortic arch, Concomitant valve surgery and Concomitant intervention at congenital anomaly.

You may not qualify if:

  • Patients with previous aortic valve surgery.
  • missing informed consent
  • Participation in another clinical research.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut university

Asyut, Egypt

Location

MeSH Terms

Conditions

Aortic Valve Disease

Condition Hierarchy (Ancestors)

Heart Valve DiseasesHeart DiseasesCardiovascular Diseases

Study Officials

  • Ali Abd Elwahab, PHD

    Assiut University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
specialist

Study Record Dates

First Submitted

March 19, 2021

First Posted

March 25, 2021

Study Start

March 30, 2021

Primary Completion

June 30, 2023

Study Completion

July 30, 2023

Last Updated

January 20, 2025

Record last verified: 2025-01

Locations